Nation | by AFP
The Hague
The European Medicines Agency said Tuesday it may decide “within weeks” whether to approve Merck’s anti-Covid pill, Lagevrio, which could offer patients an easy at-home treatment for the disease.
“EMA will assess the benefits and risks of Lagevrio under a reduced timeline and could issue an opinion within weeks if the data submitted are sufficiently robust and complete,” the body said…
